Depot medroxyprogesterone: the way forward
Article
| IMSEAR
| ID: sea-207821
ABSTRACT
India has a high rate of unintended pregnancies and abortions contribute to 8% of maternal mortality. The addition of injection depot medroxyprogesterone (DMPA) to the basket of contraceptives has allowed women to use a long-term contraceptive which does not require any user action to maintain efficacy and whose effect is easily reversible. Injectable progestins are now estimated to be used by 6% women globally.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS